A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines
Science Advances · 2026
DOI: 10.1126/sciadv.aec7827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Ryunosuke Muro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Antigen Presentation, RNA, Messenger, CD8-Positive T-Lymphocytes, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Takeda Science Foundation, Nakatomi Foundation, Uehara Memorial Foundation.
Abstract (Originalsprache)
Lipid nanoparticle–encapsulated mRNA (mRNA-LNP) vaccines trigger the potent differentiation of antigen-specific cytotoxic CD8 T cells in addition to antibody production. Despite its high immunogenicity, the cellular mechanisms by which mRNA-LNP induces such unusual immune responses remain largely unclear. Here, we show that mRNA-LNP induces potent and long-lasting CD8 T cell expansion through an antigen presentation mechanism that differs from that of conventional adjuvants. In mice immunized with mRNA-LNP, the number of antigen-specific CD8 T cells was one order of magnitude higher than that induced by combining antigen proteins with immunostimulants such as lipopolysaccharide or polyinosinic:polycytidinic acid. Intramuscularly administered mRNA-LNPs were mainly taken up by migratory type 2 conventional dendritic cells in draining lymph nodes, resulting in notably strong and persistent antigen presentation through major histocompatibility complex class I. Furthermore, CD8 T cell induction by mRNA-LNP required migratory dendritic cells but not the traditional cross-presentation pathway that is otherwise essential for antiviral and antitumor immunity. Thus, the mRNA-LNP formulation exerts unconventional immune responses through a different antigen-presentation pathway from conventional component vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
- Division of Molecular Pathology, Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan.
- Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Division of Rheumatology, Department of Medicine, University of California San Diego, La Jolla, CA, United States.
- Division of Immune Environment Dynamics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
ORCID-Profile: Ryunosuke Muro, Suqi Wang, Taku Ito-Kureha, Hung Hiep Huynh, Kouji Kobiyama, Takuya Sugita, Kazuo Okamoto, Kenta Nakano, Masato Kubo, Ken J Ishii, Takeshi Nitta, Hiroshi Takayanagi
Förderung
- Takeda Science Foundation
- Nakatomi Foundation
- Uehara Memorial Foundation
- Japan Agency for Medical Research and Development
- Cancer Research Institute, Kanazawa University
- Japan Society for the Promotion of Science
- UTOPIA Young Researcher Development Program
- Astellas Foundation for Research on Metabolic Disorders
Zitieren
APA
Muro, R., Wang, S., Ito-Kureha, T., Huynh, H. H., Kobiyama, K., Sugita, T., Okamoto, K., Nakano, K., Okamura, T., Kubo, M., Ishii, K. J., Nitta, T., & Takayanagi, H. (2026). A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines. Science Advances. https://doi.org/10.1126/sciadv.aec7827
Vancouver
Muro R, Wang S, Ito-Kureha T, Huynh HH, Kobiyama K, Sugita T, et al. A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines. Science Advances. 2026. doi:10.1126/sciadv.aec7827
BibTeX
@article{Muro2026,
author = {Muro, Ryunosuke and Wang, Suqi and Ito-Kureha, Taku and Huynh, Hung Hiep and Kobiyama, Kouji and Sugita, Takuya and Okamoto, Kazuo and Nakano, Kenta and Okamura, Tadashi and Kubo, Masato and Ishii, Ken J and Nitta, Takeshi and Takayanagi, Hiroshi},
title = {A distinct antigen presentation pathway drives potent T cell immunity in lipid nanoparticle–based mRNA vaccines},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aec7827}
}
EUVIMED